Clinical Trials Browser

Phase 2 × Glioblastoma × ruxolitinib × Clear all

NCT06991101 2025-12-26

Ruxolitinib With Radiation and Temozolomide Compared to Radiation and Temozolomide for Newly Diagnosed Glioblastoma

Phase 2 Recruiting

Brain Neoplasms, Glioblastoma